Search clinical trials for: [11C]AZ1419 3391
Total 2403 results
-
Universitaire Ziekenhuizen KU LeuvenCHDI Foundation, Inc.Not yet recruiting
-
Christine Elizabeth EdmondsWithdrawn
-
National Institute of Mental Health (NIMH)Completed
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
Antisoma ResearchCompletedLeukemia, MyeloidUnited States, New Zealand
-
Johns Hopkins UniversityUnited States Department of DefenseNot yet recruiting
-
Masaryk Memorial Cancer InstituteActive, not recruiting11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET) (GlioMET)Glioblastoma MultiformeCzechia
-
Hospices Civils de LyonRecruiting
-
BioMarin PharmaceuticalActive, not recruitingHereditary Angioedema | HAESpain, United States, Australia
-
AkesoRecruiting
-
AkesoRecruiting
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingCarcinoid Syndrome | Metastatic Nonfunctional Well Differentiated Neuroendocrine NeoplasmUnited States
-
National Institute of Mental Health (NIMH)RecruitingParkinson's Disease | Dementia | ALS | Alzheimer's DiseaseUnited States
-
Wuhan Union Hospital, ChinaRecruiting
-
Mclean HospitalNational Institute on Drug Abuse (NIDA)WithdrawnNicotine Dependence | Smoking Cue Reactivity | Relapse to SmokingUnited States
-
Columbia UniversityTerminatedBreast Cancer | Colon Cancer | NeuropathyUnited States
-
Yonsei UniversityCompleted
-
National Institute of Mental Health (NIMH)Uniformed Services University of the Health Sciences; Suburban HospitalCompletedHealthy | Traumatic Brain Injury (TBI)United States
-
Justin SimsTerminatedHepatocellular CarcinomaUnited States
-
CelgeneCompleted
-
Karolinska University HospitalUniversity of CopenhagenCompletedSurgery | Anesthesia | Neurogenic Inflammation | Cognitive Disorders
-
UCB PharmaYale University; PRA Health SciencesCompleted
-
José A. LuchsingerNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert... and other collaboratorsTerminatedAlzheimer DiseaseUnited States
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
Centre for Addiction and Mental HealthActive, not recruiting
-
National Institute of Mental Health (NIMH)Terminated
-
University of Alabama at BirminghamWithdrawn
-
Taisho Pharmaceutical R&D Inc.Yale UniversityCompleted
-
University of MichiganCompletedCardiomyopathyUnited States
-
Tammie L. S. Benzinger, MD, PhDRecruitingAlzheimer DiseaseUnited States
-
Université de SherbrookeMcMaster University; University of OttawaCompletedType2 DiabetesCanada
-
AstraZenecaRecruiting
-
AstraZenecaNot yet recruiting
-
GlaxoSmithKlineCompletedPain, InflammatorySweden
-
University of PennsylvaniaRecruiting
-
AstraZenecaRecruiting
-
Davidzon, Guido, M.D.Stanford UniversitySuspended
-
University of Alabama at BirminghamWithdrawnAcute Decompensated Heart FailureUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate Cancer PatientsUnited States
-
Orion Corporation, Orion PharmaCompleted
-
SignalChem Lifesciences CorporationCompleted
-
SignalChem Lifesciences CorporationSyneos HealthCompletedFood-drug InteractionCanada
-
Galera Therapeutics, Inc.Completed
-
University of UtahTerminatedAlzheimer's DiseaseUnited States
-
Peking University Cancer Hospital & InstituteActive, not recruiting
-
The Methodist Hospital Research InstituteRecruiting
-
University of ExeterRecruitingParkinson Disease | Neurodegenerative DiseasesUnited Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States